Romano Sarah 4
4 · KIORA PHARMACEUTICALS INC · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Romano Sarah
Interim CFO
Transactions
- Award
Stock Option (right to buy)
2022-02-01+50,000→ 50,000 totalExercise: $0.77Exp: 2032-02-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.